UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Frailty and sarcopenia: definitions and outcome parameters

Osteoporosis international, 2012-07, Vol.23 (7), p.1839-1848

2012

Volltextzugriff (PDF)

Effects of three avocado/soybean unsaponifiable mixtures on metalloproteinases, cytokines and prostaglandin E2 production by human articular chondrocytes

Clinical rheumatology, 1998, Vol.17 (1), p.31-39

1998

Volltextzugriff (PDF)

Subchondral bone osteoblasts induce phenotypic changes in human osteoarthritic chondrocytes

Osteoarthritis and cartilage, 2005-11, Vol.13 (11), p.988-997

2005

Volltextzugriff (PDF)

Correlation between radiographic severity of knee osteoarthritis and future disease progression. Results from a 3-year prospective, placebo-controlled study evaluating the effect of glucosamine sulfate

Osteoarthritis and cartilage, 2003-01, Vol.11 (1), p.1-5

2003

Volltextzugriff (PDF)

Harmonization of clinical practice guidelines for the prevention and treatment of osteoporosis and osteopenia in Europe: a difficult challenge

Calcified tissue international, 1996, Vol.59 Suppl 1 (S1), p.S24-S29

Reginster, J L

1996

Volltextzugriff (PDF)

Radiologic features poorly predict clinical outcomes in knee osteoarthritis

Scandinavian journal of rheumatology, 2002-01, Vol.31 (1), p.13-16

2002

Volltextzugriff (PDF)

Osteoblasts from the sclerotic subchondral bone downregulate aggrecan but upregulate metalloproteinases expression by chondrocytes. This effect is mimicked by interleukin-6, -1beta and oncostatin M pre-treated non-sclerotic osteoblasts

Osteoarthritis and cartilage, 2005-11, Vol.13 (11), p.979-987

2005

Volltextzugriff (PDF)

Ipriflavone: pharmacological properties and usefulness in postmenopausal osteoporosis

Bone and mineral, 1993-12, Vol.23 (3), p.223-232

Reginster, Jean-Yves L.

1993

Volltextzugriff (PDF)

Effects of nimesulide and sodium diclofenac on interleukin-6, interleukin-8, proteoglycans and prostaglandin E2 production by human articular chondrocytes in vitro

Clinical and experimental rheumatology, 1999-03, Vol.17 (2), p.151

1999

Volltextzugriff (PDF)

Calcitonins: newer routes of delivery

Osteoporosis international, 1993-01, Vol.3 Suppl 2 (S2), p.S3-7

Reginster, J Y

1993

Volltextzugriff (PDF)

Regulation by reactive oxygen species of interleukin-1beta, nitric oxide and prostaglandin E(2) production by human chondrocytes

Osteoarthritis and cartilage, 2002-07, Vol.10 (7), p.547-555

2002

Volltextzugriff (PDF)

Oral tiludronate : pharmacological properties and potential usefulness in Paget's disease of bone on osteoporosis

Bone (New York, NY), 1992, Vol.13 (5), p.351-354

REGINSTER, J. Y. L

1992

Volltextzugriff (PDF)

Trabecular bone score (TBS) as a new complementary approach for osteoporosis evaluation in clinical practice

Bone (New York, N.Y.), 2015-09, Vol.78, p.216-224

2015

Volltextzugriff (PDF)

Vitamin D supplementation in elderly or postmenopausal women: a 2013 update of the 2008 recommendations from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO)

Current medical research and opinion, 2013-04, Vol.29 (4), p.305-313

2013

Volltextzugriff (PDF)

Identification and management of patients at increased risk of osteoporotic fracture: outcomes of an ESCEO expert consensus meeting

Osteoporosis international, 2017-07, Vol.28 (7), p.2023-2034

2017

Volltextzugriff (PDF)

Benefits and safety of dietary protein for bone health—an expert consensus paper endorsed by the European Society for Clinical and Economical Aspects of Osteopororosis, Osteoarthritis, and Musculoskeletal Diseases and by the International Osteoporosis Foundation

Osteoporosis international, 2018-09, Vol.29 (9), p.1933-1948

2018

Volltextzugriff (PDF)

Is there a role for menopausal hormone therapy in the management of postmenopausal osteoporosis?

Osteoporosis international, 2020-12, Vol.31 (12), p.2271-2286

2020

Volltextzugriff (PDF)

Algorithm for the management of patients at low, high and very high risk of osteoporotic fractures

Osteoporosis international, 2020-01, Vol.31 (1), p.1-12

2020

Volltextzugriff (PDF)

How has COVID-19 affected the treatment of osteoporosis? An IOF-NOF-ESCEO global survey

Osteoporosis international, 2021-04, Vol.32 (4), p.611-617

2021

Volltextzugriff (PDF)

Interventions to improve adherence to anti-osteoporosis medications: an updated systematic review

Osteoporosis international, 2020-09, Vol.31 (9), p.1645-1669

2020

Volltextzugriff (PDF)

Phosphate wasting disorders in adults

Osteoporosis international, 2018-11, Vol.29 (11), p.2369-2387

2018

Volltextzugriff (PDF)

Relationship Between Bone Mineral Density T‐Score and Nonvertebral Fracture Risk Over 10 Years of Denosumab Treatment

Journal of bone and mineral research, 2019-06, Vol.34 (6), p.1033-1040

2019

Volltextzugriff (PDF)

Abaloparatide for risk reduction of nonvertebral and vertebral fractures in postmenopausal women with osteoporosis: a network meta-analysis

Osteoporosis international, 2019-07, Vol.30 (7), p.1465-1473

2019

Volltextzugriff (PDF)

Bone health assessment in older people with or without muscle health impairment

Osteoporosis international, 2018-05, Vol.29 (5), p.1057-1067

2018

Volltextzugriff (PDF)

The position of strontium ranelate in today’s management of osteoporosis

Osteoporosis international, 2015-06, Vol.26 (6), p.1667-1671

2015

Volltextzugriff (PDF)

1 – 25 von 285

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(259)
Mit Volltextzugriff
(219)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Frailty and sarcopenia: definitions and outcome parameters

Effects of three avocado/soybean unsaponifiable mixtures on metalloproteinases, cytokines and prostaglandin E2 production by human articular chondrocytes

Subchondral bone osteoblasts induce phenotypic changes in human osteoarthritic chondrocytes

Correlation between radiographic severity of knee osteoarthritis and future disease progression. Results from a 3-year prospective, placebo-controlled study evaluating the effect of glucosamine sulfate

Harmonization of clinical practice guidelines for the prevention and treatment of osteoporosis and osteopenia in Europe: a difficult challenge

Radiologic features poorly predict clinical outcomes in knee osteoarthritis

Osteoblasts from the sclerotic subchondral bone downregulate aggrecan but upregulate metalloproteinases expression by chondrocytes. This effect is mimicked by interleukin-6, -1beta and oncostatin M pre-treated non-sclerotic osteoblasts

Ipriflavone: pharmacological properties and usefulness in postmenopausal osteoporosis

Effects of nimesulide and sodium diclofenac on interleukin-6, interleukin-8, proteoglycans and prostaglandin E2 production by human articular chondrocytes in vitro

Calcitonins: newer routes of delivery

Regulation by reactive oxygen species of interleukin-1beta, nitric oxide and prostaglandin E(2) production by human chondrocytes

Oral tiludronate : pharmacological properties and potential usefulness in Paget's disease of bone on osteoporosis

Trabecular bone score (TBS) as a new complementary approach for osteoporosis evaluation in clinical practice

Vitamin D supplementation in elderly or postmenopausal women: a 2013 update of the 2008 recommendations from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO)

Identification and management of patients at increased risk of osteoporotic fracture: outcomes of an ESCEO expert consensus meeting

Benefits and safety of dietary protein for bone health—an expert consensus paper endorsed by the European Society for Clinical and Economical Aspects of Osteopororosis, Osteoarthritis, and Musculoskeletal Diseases and by the International Osteoporosis Foundation

Is there a role for menopausal hormone therapy in the management of postmenopausal osteoporosis?

Algorithm for the management of patients at low, high and very high risk of osteoporotic fractures

How has COVID-19 affected the treatment of osteoporosis? An IOF-NOF-ESCEO global survey

Interventions to improve adherence to anti-osteoporosis medications: an updated systematic review

Phosphate wasting disorders in adults

Relationship Between Bone Mineral Density T‐Score and Nonvertebral Fracture Risk Over 10 Years of Denosumab Treatment

Abaloparatide for risk reduction of nonvertebral and vertebral fractures in postmenopausal women with osteoporosis: a network meta-analysis

Bone health assessment in older people with or without muscle health impairment

The position of strontium ranelate in today’s management of osteoporosis

Suchergebnisse filtern